Capricor Announces Positive One-Year Results from HOPE-2 Open Label Extension Study Evaluating CAP-1002 ...
Italfarmaco Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Duchenne ...
Edgewise Announces Positive 2-Month Interim Results from Open Label Study of EDG-5506 in Adults with Becker ...
NS Pharma Announces Publication of Long-Term Efficacy and Safety Data of VILTEPSO® (Viltolarsen) in Duchenne ...
3 Amazing Keynotes Announced For PPMD’s 2022 Conference — Including YouTube Stars Shane & Hannah Burcaw! ...
